Shogo Shimizu

Surface-Modified Nanoparticles Enhance Transurothelial Penetration and Delivery of Survivin siRNA in Treating Bladder Cancer

Darryl T. Martin, Jill M. Steinbach-Rankins, Jingchun Liu et al. · Molecular Cancer Therapeutics · 2013 · 78 citations · Full text

Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.

Yoshihito Uchida, Masaki Nakamura, Shogo Shimizu et al. · PubMed · 1983 · 77 citations

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +20

Nicorandil ameliorates ischaemia‐reperfusion injury in the rat kidney

Shogo Shimizu, Motoaki Saito, Yukako Kinoshita et al. · British Journal of Pharmacology · 2011 · 74 citations · Full text

One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial

Masahiro Natsuaki, Takeshi Morimoto, Erika Yamamoto et al. · Cardiovascular Intervention and Therapeutics · 2015 · 73 citations · Full text

Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH

Motoaki Saito, Panagiota Tsounapi, Ryo Oikawa et al. · Scientific Reports · 2014 · 69 citations · Full text